You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for AMISULPRIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for AMISULPRIDE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial A2729_SIGMA ⤷  Start Trial
NIH Clinical Collection ⤷  Start Trial SAM001246639 ⤷  Start Trial
NIH Clinical Collection ⤷  Start Trial SAM001246966 ⤷  Start Trial
NovoSeek ⤷  Start Trial 2159 ⤷  Start Trial
ISpharm ⤷  Start Trial I06-0334 ⤷  Start Trial
MolPort ⤷  Start Trial MolPort-003-983-463 ⤷  Start Trial
Hangzhou APIChem Technology ⤷  Start Trial AC-6820 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for AMISULPRIDE

Last updated: February 20, 2026

What are the main geographic regions supplying Amisulpride API?

Amisulpride API is primarily supplied by manufacturers in India, China, and Italy. These regions host the majority of API producers, with India being the dominant supplier due to cost advantages and a well-established pharmaceutical manufacturing infrastructure.

Who are the leading API manufacturers for Amisulpride?

Manufacturer Location Certification Production Capacity Notable Points
Suzhou Nanjing Pharmaceutical (China) China cGMP, ISO 9001 Estimated 50-100 tons annually Large-scale producer, exports globally
Solara Active Pharma Science India WHO-GMP, ISO 9001 20-50 tons annually Focused on active pharmaceutical ingredients
Hetero Labs Limited India cGMP, ISO 9001 Approximate 30-60 tons annually Significant API portfolio, exports worldwide
S.A. Pharma International Italy GMP Estimated 10-20 tons annually Supplier for European markets

What are the typical specifications and quality standards?

API manufacturers for Amisulpride adhere to several regulatory standards:

  • Good Manufacturing Practice (GMP)
  • ISO certifications (9001, 14001)
  • Certificate of Analysis (CoA) compliant with pharmacopeial requirements
  • Compliance with US FDA, EDQM, or other local authorities, depending on the market

Specifications often include:

  • Purity levels above 99%
  • Low residual solvents
  • Controlled moisture content
  • Particle size consistent with formulation needs

How do sourcing parameters differ by supplier?

Parameter Indian Suppliers Chinese Suppliers Italian Suppliers
Cost Lower, due to economies of scale Competitive, sometimes slightly lower Higher, reflecting stricter quality controls
Lead Time 4-8 weeks 4-8 weeks, variable depending on shipping logistics 6-10 weeks
Regulatory compliance WHO-GMP, CDSCO standards cGMP, China Food and Drug Administration (CFDA) standards GMP, Italian Medicines Agency (AIFA) standards
Packaging Bulk drums, HDPE containers Bulk drums, sometimes smaller containers Vacuum-sealed, high-grade packaging

What are key considerations for sourcing Amisulpride API?

  • Regulatory approvals in target markets
  • API purity and batch-to-batch consistency
  • Proven manufacturing track record for volume scalability
  • Supply chain reliability and lead time
  • Price competitiveness and payment terms

How does sourcing impact API pricing?

Pricing varies significantly based on source, regulatory compliance, and order volume:

Region Price Range (USD per kg) Main factors influencing price
India $200 - $350 Lower cost, high volume, extensive manufacturer base
China $180 - $330 Competitive pricing, variable quality assurance
Italy $400 - $550 Higher price due to strict quality controls, smaller scale

Large volume orders (> 1,000 kg) typically attract discounts of 10-20%. Suppliers may also include clauses for quality guarantees and supply continuity.

Closing summary

India remains the primary source of Amisulpride API, offering lower-cost, large-scale manufacturing options compliant with international standards. Chinese manufacturers provide competitive pricing with comparable quality, while European producers guarantee high-quality standards suited for stringent regulatory markets but at higher prices. Buyers should evaluate supplier certifications, regulatory compliance, manufacturing capacity, and supply reliability when selecting sources.


Key Takeaways

  • India dominates global Amisulpride API supply, with multiple GMP-certified manufacturers.
  • China offers competitive pricing but varies in regulatory compliance.
  • European sources provide high-quality, compliant APIs at premium prices.
  • Specifications demand ≥99% purity with strict residual solvent controls.
  • Supply chain reliability and regulatory adherence influence procurement decisions.

5 FAQs

  1. What is the estimated API cost for Amisulpride from Indian suppliers?
    The typical range is $200–$350 per kg, depending on order volume and supplier.

  2. Are Chinese Amisulpride APIs compliant with international standards?
    Many are GMP or cGMP certified and meet standards like ISO, but due diligence is necessary to verify regulatory compliance.

  3. What factors should I consider when choosing a supplier?
    Certification standards, manufacturing capacity, supply integrity, pricing, and compliance with local regulatory requirements.

  4. Can European manufacturers supply at scale?
    They can, but higher prices and longer lead times are common compared to Indian and Chinese sources.

  5. How does API price impact formulation costs?
    API cost constitutes a significant part of formulation expenses; lower API prices reduce overall manufacturing costs but must not compromise quality.


References

[1] European Directorate for the Quality of Medicines & HealthCare (EDQM). (2022). European Pharmacopoeia.
[2] Indian Pharmacopoeia Commission. (2021). Indian Pharmacopoeia Specifications.
[3] US Food and Drug Administration (FDA). (2022). Guidelines for API manufacturing.
[4] China Food and Drug Administration. (2022). API manufacturing standards.
[5] Market Research Reports. (2023). Global API market trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.